We can share the fantastic news that a Letter of Intent (LOI) has been signed between Thermaiscan and MAMTA Health Institute for Mother and Child (MAMTA-HIMC), a leading national-level not-for-profit organisation that works across 20 states in India.
MAMTA-HIMC, is a New Delhi-based not-for-profit organization, working for more than three decades in the areas of health and development for improving the quality of life of the marginalized and vulnerable population in India and in the region. Currently, it is implementing its project directly in 16 states, and in addition it works in collaboration with network partners in other 4 states across the country. It works very closely with community structures at district and state health facilities, both in the public and private sectors.
Thermaiscan is a Swedish software company within the predictive medicine field. Our mission is to solve the problem of late detection of breast cancer development on a global level. Thermaiscan’s innovation is a breast cancer pre-screening solution based on inhouse developed AI, combined with already existing thermal sensors in smartphones. The goal is to enhance B2B health units – such as mini-clinics, primary care and rural healthcare non-specialists – with the ability to perform breast cancer pre-screening and detect breast abnormalities in early stages. Finding breast cancer early is strongly correlated with better survival chances. Thermaiscan’s approach with a portable, affordable and non-toxic breast cancer pre-screening solution with cutting edge technology has caught interest & been rewarded in India and Singapore. The vision is to have it acting as a complement to current screening methods in the hands of first-line healthcare non-specialist workers.
Thermaiscan Breast Cancer Pre-Screening solution was 1 of 14 winners in India-Sweden Innovation Challenge at the end of November 2020 during Covid-19 pandemic. Thermaiscan has since 2021 received tremendous support from the India-Sweden Healthcare Innovation Centre. The support includes a partnership between India’s premier healthcare institutions AIIMS Delhi, AIIMS Jodhpur and Business Sweden, closely guided by the Ministry of Health (including ICMR) in Sweden and India, along with Knowledge Partner AstraZeneca as well as Technology Partner NASSCOM.
There is a significant increase in the number of cancer patients in India from 1990 to 2016, as per the report published in the Lancet. The crude cancer incidence rate in India has increased by 28.2% owing to various environmental and genetic factors. Breast cancer accounts for 8.2% of total cancer cases in India. Therefore, the government of India has started looking for AI-based diagnosing approaches for the diagnosis of various types of cancer.
In India, about 1 in 28 women are expected to develop breast cancer during their lifetime. It is crucial to have portable, simple and affordable screening solutions both for non-specialists in healthcare and for the end users – the millions of women in India who don’t have access to screenings or specialists. In India, the cost of a Mammography ranges from INR 800 and could go up to INR 3000. More than 25% of India’s population has a monthly income of less than INR 1,000, and this price for many women is not affordable. This means several women at risk in India are unable to understand the early signs of breast cancer.
This is MAMTA-HIMC
MAMTA-HIMC, was founded by a well-known practicing pediatrician, Dr Sunil Mehra, by designing interventions for the underprivileged communities in the Tigri slums of south Delhi in 1990. Since then the organization has developed initiatives focused on strengthening the health system; and developing partnerships and networks that promote healthcare of marginalized people.
During these years, MAMTA-HIMC has promoted strategic solutions, policies and programming, research and global learning in the fields of Maternal Newborn Child Health and Nutrition, Young People’s Sexual Reproductive Health and Rights, HIV, TB and Non-Communicable Diseases, with a special focus on promoting rights, gender equality and equity.
In the normal course, MAMTA-HIMC mobilizes the community, build the capacities of health systems, evidence generation on various determinants of healthcare, network with like-minded institutions/civil societies and nudge the government on evidence-based programming.
The focus area for MAMTA includes maternal, newborn child health and nutrition, pre-pregnancy, ante-natal care and post-partum and sexual reproductive health. It further works towards young people’s sexual reproductive health and rights, and its key determinants such as adverse gender norms, early/child marriage, and nutrition. In addition, the organization promotes awareness on the prevention of communicable diseases and non-communicable diseases along with a comprehensive healthcare support system for early detection and referral services for HIV, TB, diabetes, hypertension, cardiovascular disease, and cancer among marginalized communities.
Read more at mamta-himc.in
Thermal technology can transform the healthcare
Thermal technology is rapidly evolving and sensors are becoming smaller, more sensitive and better. The healthcare system can take advantage of this evolution and Thermaiscan is part of building this new future.
In May 2022, Anna Riby, Regional Director at the Swedish organization Swecare arranged a meeting between the founder and Executive Director of MAMTA-HIMC, Dr Sunil Mehra, and the Thermaiscan’s co-founder and COO, Arby Leonian. The meeting went well, and since then relationships have been established and a common understanding has been reached to sign LOI.
Once the Thermaiscan Breast Cancer Pre-Screening has passed clinical trials and a medical paper has been published, MAMTA-HIMC will start a community-based evaluation of the product. Through its extensive reach across 20 states in India, MAMTA-HIMC will support its uptake in public and private health facilities.
This is Swecare
Swecare is a unique non-profit platform where academia, public and private sector join forces toward enhanced export and internationalization of Swedish health care and life science. Swecare was founded in 1978 by the Swedish government and the healthcare industry together as a semi-governmental non-profit organization.
Today, Swecare has more than 100 Swedish companies and organizations in its network. The members represent the entire health care spectrum – from the small startup company to university hospitals, regions, and global corporations, working with everything from biotech to medical technology, pharmaceuticals, and health care services.Swecare’s work is based on the triple helix model where academia, public sector, and private sector jointly address health care challenges. Joining forces and addressing problems from multiple angles in turn increases collaboration and international competitiveness of Swedish health care.
Read more at swecare.se
 Breast Cancer in India, The Times of India, June 30, 2020
 25% of India’s population still poor, says Niti Aayog, Hindustan Times, Nov 28, 2021